Post-market Study of the Biodesign Hernia Graft
Ventral HerniaThe purpose of this study is to collect data on the performance of the Biodesign® Hernia Graft when used to reinforce soft tissues during ventral hernia repair.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
1. Primary or recurrent ventral hernia in need of surgical repair utilizing a Biodesign Hernia Graft
Exclusion Criteria:
1. Known sensitivity to porcine material
For the study, the following patients will also be excluded:
2. Age \< 18 years
3. Unable or unwilling to provide informed consent
4. Life expectancy of less than one year from the date of the index procedure
5. Patients will be excluded from the study if they never receive a Biodesign Hernia Graft during their index procedure.
Study Location
St. Paul's Hospital
St. Paul's HospitalVancouver, British Columbia
Canada
Contact Study Team
Queen Elizabeth II Hospital
Queen Elizabeth II HospitalHalifax, Nova Scotia
Canada
Contact Study Team
- Study Sponsored By
- Cook Biotech Incorporated
- Participants Required
- More Information
- Study ID:
NCT04294446